Anterior Cruciate Ligament Rupture

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Providence Therapeutics
1 program
ACL repair without anterolateral repairN/A1 trial
Active Trials
NCT04373408UnknownEst. Dec 2023
Arthrex
ArthrexCA - Santa Barbara
1 program
Fertilized ACLN/A1 trial
Active Trials
NCT06294314RecruitingEst. Jul 2028

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
ArthrexFertilized ACL
Providence TherapeuticsACL repair without anterolateral repair

Clinical Trials (2)

NCT06294314ArthrexFertilized ACL

Return to Play After ACL Reconstruction With Bone Marrow Aspirate, DBM, and an Internal Brace

Start: Feb 2024Est. completion: Jul 2028
N/ARecruiting
NCT04373408Providence TherapeuticsACL repair without anterolateral repair

ALL Ultrasound Predicts the Success of ACL Repair?

Start: Jul 2020Est. completion: Dec 2023
N/AUnknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space